Literature DB >> 11136631

Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up.

A Bateman1, P Fonagy.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the substantial gains made by patients with borderline personality disorder following completion of a psychoanalytically oriented partial hospitalization program, in comparison to patients treated with standard psychiatric care, were maintained over an 18-month follow-up period.
METHOD: Forty-four patients who participated in the original study were assessed every 3 months after completion of the treatment phase. Outcome measures included frequency of suicide attempts and acts of self-harm, number and duration of inpatient admissions, service utilization, and self-reported measures of depression, anxiety, general symptom distress, interpersonal functioning, and social adjustment.
RESULTS: Patients who completed the partial hospitalization program not only maintained their substantial gains but also showed a statistically significant continued improvement on most measures in contrast to the patients treated with standard psychiatric care, who showed only limited change during the same period.
CONCLUSIONS: The superiority of psychoanalytically oriented partial hospitalization over standard psychiatric treatment found in a previous randomized, controlled trial was maintained over an 18-month follow-up period. Continued improvement in social and interpersonal functioning suggests that longer-term changes were stimulated.

Entities:  

Mesh:

Year:  2001        PMID: 11136631     DOI: 10.1176/appi.ajp.158.1.36

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  63 in total

1.  All you need is cognitive behaviour therapy? Critical appraisal of evidence base must be understood and respected.

Authors:  Tom Sensky; Jan Scott
Journal:  BMJ       Date:  2002-06-22

Review 2.  Common factors in empirically supported treatments of borderline personality disorder.

Authors:  Igor Weinberg; Elsa Ronningstam; Mark J Goldblatt; Mark Schechter; John T Maltsberger
Journal:  Curr Psychiatry Rep       Date:  2011-02       Impact factor: 5.285

3.  Psychotherapy of Borderline Personality Disorder: Can the Supply Meet the Demand? A German Nationwide Survey in DBT Inpatient and Day Clinic Treatment Facilities.

Authors:  Christoph Richter; Bruno Steinacher; Anna zum Eschenhoff; Felix Bermpohl
Journal:  Community Ment Health J       Date:  2015-09-01

4.  Psychoanalysis today.

Authors:  Peter Fonagy
Journal:  World Psychiatry       Date:  2003-06       Impact factor: 49.548

5.  Personality disorder in psychiatric practice.

Authors:  Peter Tyrer; Erik Simonsen
Journal:  World Psychiatry       Date:  2003-02       Impact factor: 49.548

6.  Systems Training for Emotional Predictability and Problem Solving (STEPPS) for outpatients with borderline personality disorder: a randomized controlled trial and 1-year follow-up.

Authors:  Nancee Blum; Don St John; Bruce Pfohl; Scott Stuart; Brett McCormick; Jeff Allen; Stephan Arndt; Donald W Black
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

7.  Psychological interventions for obsessive-compulsive personality disorder.

Authors:  Rajesh Alex; Michael Ferriter; Hannah Jones; Conor Duggan; Nick Huband; Simon Gibbon; Birgit A Völlm; Jutta Stoffers; Klaus Lieb
Journal:  Cochrane Database Syst Rev       Date:  2010

8.  Patterns of Emotional Availability between Mothers and Young Children: Associations with Risk Factors for Borderline Personality Disorder.

Authors:  Rebecca D Trupe; Jenny Macfie; Rebecca M Skadberg; Gretchen Kurdziel
Journal:  Infant Child Dev       Date:  2017-06-21

9.  Clinical problems in community mental health care for patients with severe borderline personality disorder.

Authors:  B Koekkoek; B van Meijel; A Schene; G Hutschemaekers
Journal:  Community Ment Health J       Date:  2009-10-22

10.  Secondary prevention of suicide.

Authors:  Debora Ganz; M Dolores Braquehais; Leo Sher
Journal:  PLoS Med       Date:  2010-06-01       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.